+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Biotechnology Market - Global Forecast 2026-2032- Product Image
Animal Biotechnology Market - Global Forecast 2026-2032- Product Image
New

Animal Biotechnology Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5264368
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The animal biotechnology market is entering a phase marked by accelerated innovation, increased operational complexity, and evolving regulatory demands. Senior leaders in animal health must balance emerging opportunities with informed, agile strategies to maintain competitiveness and foster sustainable growth.

Market Snapshot: Animal Biotechnology Market Growth Outlook

The animal biotechnology market is projected to experience robust growth, rising from USD 33.81 billion in 2025 to USD 36.49 billion in 2026, and anticipated to reach USD 60.56 billion by 2032 at a CAGR of 8.68%. This trajectory underscores a global shift as investment intensifies in biotechnologies reshaping animal health, productivity, and supply chain effectiveness. Not only do enhancements in product development fuel this progress, but distinct regional deployment strategies and regulatory adaptations are refining how solutions reach the market.

Scope & Segmentation: Strategic Insights Across the Value Chain

  • Product Types: Recombinant proteins such as antibodies and performance-related enzymes (lipases, phytases, proteases) form a core market segment, augmented by growth hormones and an expanding array of vaccines using DNA, inactivated, live attenuated, and subunit platforms.
  • Enabling Technologies: Central to market advancement are cell culture systems (including avian, insect, and mammalian options), advanced gene editing tools, synthetic biology, and molecular diagnostics like PCR and DNA sequencing, all facilitating scalable R&D and streamlined production processes.
  • Applications: The market’s breadth covers diagnostics with platforms such as ELISA, lateral flow, and PCR assays, drug discovery with a focus on lead optimization and preclinical models, and a suite of feed additives aimed at improving animal nutrition and overall performance.
  • End-Users: Diverse end-user groups—including animal farms, contract research organizations, pharmaceutical manufacturers, and research laboratories—each play distinct roles in technology adoption and market expansion initiatives.
  • Regions: Regional segmentation reflects differing growth drivers: the Americas leverage established R&D infrastructure, Europe, and the Middle East & Africa navigate diverse regulatory settings, while Asia-Pacific demonstrates rapid uptake of diagnostics and vaccines alongside ongoing production scale-up.

Key Takeaways: Strategic Considerations for Decision Makers

  • Emerging molecular biology and sequencing advancements enable precise therapeutic and diagnostic innovations, reinforcing product differentiation within animal health and productivity segments.
  • Operational resilience is increasing as modular biomanufacturing models and distributed production set-ups allow organizations to adjust more rapidly to changing compliance and market requirements.
  • Strategic partnerships—with both contract research and manufacturing organizations—are critical in bridging laboratory advances and scalable, commercially viable products, speeding time-to-market while spreading development risk.
  • Segmentation-driven portfolio decisions now rely on connected intelligence, aligning technology investment with targeted customer needs to optimize adoption and market penetration.
  • Region-specific regulatory considerations are prompting tailored approaches to data collection and compliance, with local expertise acting as a competitive differentiator in market entry and expansion.

Tariff Impact: Navigating Evolving Supply Chain Dynamics

Recent changes in tariff and trade policies are prompting animal biotechnology organizations to reexamine procurement and manufacturing strategies. By diversifying their supplier bases, increasing local manufacturing, and optimizing inventory management, companies are aiming to maintain cost efficiency and operational continuity. The adoption of parallel sourcing and new partnerships is now standard practice to minimize disruption risks in reagent availability and import logistics, supporting steady research and manufacturing activity.

Methodology & Data Sources

This report is grounded in a structured, mixed-methods approach. Key elements include direct interviews with industry experts, comprehensive literature analysis, incorporation of regulatory and patent information, and the use of triangulation to validate each insight. Capability mapping and scenario planning further enhance the reliability and transparency of our strategic recommendations.

Why This Report Matters

  • Delivers actionable market intelligence tailored for investment, risk management, and partnership development within the evolving animal biotechnology sector.
  • Empowers senior leaders with frameworks for effective segmentation, regulatory navigation, and operational best practices designed to optimize innovation and ensure robust supply chains.
  • Supports informed decision-making with a focus on sustained competitiveness and growth across all market segments.

Conclusion

As the animal biotechnology market evolves and new technologies redefine sector priorities, organizations that integrate innovation with efficient operations and adaptive regulatory strategies will be best positioned for continued success in animal health and productivity.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Animal Biotechnology Market, by Product Type
8.1. Recombinant Proteins
8.1.1. Antibodies
8.1.2. Enzymes
8.1.2.1. Lipases
8.1.2.2. Phytases
8.1.2.3. Proteases
8.1.3. Growth Hormones
8.2. Vaccines
8.2.1. DNA Vaccines
8.2.2. Inactivated Vaccines
8.2.3. Live Attenuated Vaccines
8.2.4. Subunit Vaccines
9. Animal Biotechnology Market, by Technology
9.1. Cell Culture
9.1.1. Avian Cell Culture
9.1.2. Insect Cell Culture
9.1.3. Mammalian Cell Culture
9.2. Genetic Engineering
9.2.1. Gene Editing
9.2.2. Gene Synthesis
9.2.3. Transgenic Technology
9.3. PCR And DNA Sequencing
9.3.1. Next-Generation Sequencing
9.3.2. PCR Kits
9.3.3. Sanger Sequencing
10. Animal Biotechnology Market, by Application
10.1. Diagnostics
10.1.1. ELISA Kits
10.1.2. Lateral Flow Assays
10.1.3. PCR-Based Tests
10.2. Drug Discovery
10.2.1. Lead Optimization
10.2.2. Preclinical Testing
10.2.3. Target Identification
10.3. Feed Additives
10.3.1. Carbohydrases
10.3.2. Phytases
10.3.3. Proteases
11. Animal Biotechnology Market, by End-User
11.1. Animal Farms
11.2. Contract Research Organizations
11.3. Pharmaceutical Companies
11.4. Research Laboratories
12. Animal Biotechnology Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Animal Biotechnology Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Animal Biotechnology Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Animal Biotechnology Market
16. China Animal Biotechnology Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Animal Genetics, Inc.
17.6. Bio-Rad Laboratories, Inc.
17.7. Biogénesis Bagó S.A.
17.8. Boehringer Ingelheim International GmbH
17.9. Ceva Santé Animale S.A.
17.10. Dechra Pharmaceuticals plc
17.11. Elanco Animal Health Incorporated
17.12. Genus plc
17.13. Hendrix Genetics BV
17.14. HIPRA S.A.
17.15. IDEXX Laboratories, Inc.
17.16. Merck & Co., Inc.
17.17. Neogen Corporation
17.18. Phibro Animal Health Corporation
17.19. Recombinetics, Inc.
17.20. Thermo Fisher Scientific Inc.
17.21. Trans Ova Genetics, LC
17.22. Vetoquinol S.A.
17.23. Virbac S.A.
17.24. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROWTH HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROWTH HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DNA VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DNA VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INACTIVATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INACTIVATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SUBUNIT VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SUBUNIT VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY AVIAN CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY AVIAN CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY AVIAN CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INSECT CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INSECT CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INSECT CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE EDITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE EDITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LATERAL FLOW ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LATERAL FLOW ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR-BASED TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR-BASED TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR-BASED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRECLINICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRECLINICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 192. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 194. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 195. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 196. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 197. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 200. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 201. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 204. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 205. EUROPE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 220. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 222. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 223. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 224. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 225. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 227. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 228. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 229. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 231. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 233. AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 252. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 253. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 254. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 255. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 256. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 257. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 258. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 260. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 261. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 262. ASEAN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 263. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 265. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 266. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 267. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 268. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 269. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 270. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 271. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 272. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 274. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 275. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 276. GCC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 291. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 292. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 294. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 295. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 296. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 297. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 298. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 299. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 300. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 301. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 302. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 303. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 304. BRICS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 305. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 306. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 307. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 308. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 309. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 310. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 311. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 312. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 313. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2032 (USD MILLION)
TABLE 314. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 316. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2032 (USD MILLION)
TABLE 317. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2032 (USD MILLION)
TABLE 318. G7 ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 319. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 320. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 321. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 322. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2032 (USD MILLION)
TABLE 323. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 324. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 325. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2032 (USD MILLION)
TABLE 326. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2032 (USD MILLION)
TABLE 327. NATO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUEN

Companies Mentioned

The key companies profiled in this Animal Biotechnology market report include:
  • Animal Genetics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biogénesis Bagó S.A.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals plc
  • Elanco Animal Health Incorporated
  • Genus plc
  • Hendrix Genetics BV
  • HIPRA S.A.
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Phibro Animal Health Corporation
  • Recombinetics, Inc.
  • Thermo Fisher Scientific Inc.
  • Trans Ova Genetics, LC
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.49 Billion
Forecasted Market Value ( USD ) by 2032 $ 60.56 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Animal Biotechnology Global Market Report 2025 - Product Image

Animal Biotechnology Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From
International Journal of Animal Biotechnology and Applications - Product Image

International Journal of Animal Biotechnology and Applications

  • Journal Icon Journal
  • Global
From
Animal Biotechnology Market 2025-2029 - Product Image

Animal Biotechnology Market 2025-2029

  • Report
  • 252 Pages
  • Global
From
2025 Global Forecast for Animal Biotechnology (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Animal Biotechnology (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Food Biotechnology Market - Global Forecast 2026-2032 - Product Image

Food Biotechnology Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From

About the Market

Animal biotechnology is a branch of biotechnology that focuses on the application of genetic engineering and other molecular biology techniques to animals. It is used to modify the genetic makeup of animals to produce desired traits, such as disease resistance, improved growth, and improved production of food and other products. Animal biotechnology is used in a variety of industries, including agriculture, pharmaceuticals, and veterinary medicine. Animal biotechnology is used to develop new animal models for research, to improve animal health and welfare, and to produce new animal-derived products. It is also used to develop new animal-derived pharmaceuticals, such as vaccines and antibodies, and to produce transgenic animals for use in biomedical research. Animal biotechnology is a rapidly growing field, with many companies investing in research and development. Examples of companies in the animal biotechnology market include Genus plc, Recombinetics, Inc., and Genocea Biosciences, Inc. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.